BCR-ABL tyrosine kinase inhibitors

M I 100 Pill - orange round, 9mm

Pill with imprint M I 100 is Orange, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Mylan Pharmaceuticals Inc.

Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Acute Lymphoblastic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imatinib (Imatinib [ im-ma-ta-nib ])-M I 100-100 mg-Orange-Round

Imatinib
Generic Name: imatinib [ im-ma-ta-nib ]
Imprint: M I 100
Strength: 100 mg
Color: Orange
Size: 9.00 mm
Shape: Round
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-2245
Inactive Ingredients: Silicon dioxide, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Magnesium silicate, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs